CN Patent

CN110893181A — 治疗超重和肥胖症的方法

Assigned to Nabc Pharmaceutical Co Ltd · Expires 2020-03-20 · 6y expired

What this patent protects

本公开内容涉及使用纳曲酮+安非他酮来治疗超重和肥胖症的组合物、试剂盒、用途、系统和方法，优选组合基于网络和/或基于电话的综合体重管理计划，并且优选在具有增加的不良心血管结果风险的对象中进行所述治疗。

USPTO Abstract

本公开内容涉及使用纳曲酮+安非他酮来治疗超重和肥胖症的组合物、试剂盒、用途、系统和方法，优选组合基于网络和/或基于电话的综合体重管理计划，并且优选在具有增加的不良心血管结果风险的对象中进行所述治疗。

Drugs covered by this patent

Patent Metadata

Patent number: CN110893181A
Jurisdiction: CN
Classification: —
Expires: 2020-03-20
Drug substance claim: No
Drug product claim: No
Assignee: Nabc Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.